A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows. The study is the first to demonstrate an intravenous medication that can cross the blood-brain barrier. The discovery could one day enable … Continue reading Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer